NewsVenture Capital12/09/2024
MBX Biosciences IPO
Norwest Venture Partners →MBX Biosciences announced IPO pricing, with Nasdaq trading expected September 13 and completion expected September 16, 2024. A separate issuer release confirms closing September 16 with full underwriter-option exercise. This does not prove full Norwest disposal.